Freenome

Freenome is a rapidly growing biotechnology company revolutionizing early cancer detection with its innovative, non-invasive blood tests. We leverage a cutting-edge multiomics platform, combining tumor and non-tumor signals with advanced machine learning, to identify cancers at their earliest, most treatable stages. This approach significantly improves patient outcomes and transforms the landscape of disease management. Our initial focus is on colorectal cancer, but our ambition extends to a broader range of cancers. We are building the clinical and operational evidence to drive widespread adoption of our technology, improving screening accessibility and saving lives. Our engineering team utilizes a robust tech stack including Python for backend development, Docker and Kubernetes for containerization and orchestration, and cloud platforms such as AWS, Azure, or GCP. We embrace agile methodologies, fostering a collaborative and supportive environment where engineers can mentor each other and champion best practices. Our high-performing culture prioritizes innovation, transparency, and a shared commitment to our mission. We offer remote work options for many roles, providing flexibility and inclusivity. Freenome is driven by a commitment to empower individuals to prevent, detect, and treat diseases proactively. Our mission is to reinvent disease management through systematized early detection and intervention. We value diversity and are proud to be an equal-opportunity employer. Backed by significant funding, we've achieved substantial milestones and continue to expand our team to meet the increasing demand for our life-changing technology. We are actively seeking talented individuals to join our mission. We are a medium-sized company with a global impact, committed to continuous growth and development of our employees. We provide competitive compensation and benefits packages including pre-IPO equity, and cash bonuses, reflecting our belief in our team's contributions and commitment.